These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
5. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland]. Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z. Pneumonol Alergol Pol; 2010 Oct; 78(4):256-62. PubMed ID: 20665445 [Abstract] [Full Text] [Related]
6. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey. Yüksel P, Tansel O. New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692 [Abstract] [Full Text] [Related]
11. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S, Bergval IL, Schuitema AR, de Beer JL, Phelan J, de Zwaan R, Clark TG, van Soolingen D, Anthony RM. BMC Infect Dis; 2017 Jul 12; 17(1):491. PubMed ID: 28697808 [Abstract] [Full Text] [Related]
15. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines. Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF. Int J Tuberc Lung Dis; 1997 Feb 12; 1(1):59-63. PubMed ID: 9441060 [Abstract] [Full Text] [Related]
16. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains. Dormandy J, Somoskovi A, Kreiswirth BN, Driscoll JR, Ashkin D, Salfinger M. Chest; 2007 Feb 12; 131(2):497-501. PubMed ID: 17296653 [Abstract] [Full Text] [Related]
18. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Abate G, Miörner H, Ahmed O, Hoffner SE. Int J Tuberc Lung Dis; 1998 Jul 12; 2(7):580-4. PubMed ID: 9661826 [Abstract] [Full Text] [Related]
19. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan. Khan MT, Malik SI, Ali S, Sheed Khan A, Nadeem T, Zeb MT, Masood N, Afzal MT. Microb Drug Resist; 2018 Nov 12; 24(9):1417-1421. PubMed ID: 29584579 [Abstract] [Full Text] [Related]
20. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China. Che Y, Bo D, Lin X, Chen T, He T, Lin Y. BMC Infect Dis; 2021 Jun 25; 21(1):605. PubMed ID: 34171989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]